Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL243977 | 1.00 | — | — | |
| Methyl Alcohol SCHEMBL11583267 | 0.95 | — | — | |
| SCHEMBL3793 | 0.95 | — | — | |
| Water SCHEMBL5185846 | 0.90 | — | — | |
| Bromide SCHEMBL3798899 | 0.90 | — | — | |
| Methyl Alcohol SCHEMBL11662814 | 0.90 | — | — | |
| Methyl Alcohol SCHEMBL11568348 | 0.86 | — | — | |
| SCHEMBL28613907 | 0.86 | — | — | |
| SCHEMBL9366540 | 0.82 | ALDH1A1 (0.33) | ALDH1A1TSHR | |
| Tromethamine SCHEMBL8530527 | 0.77 | MEN1 (0.59) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022115069-A2 | NASAL SOLUTION WITH ANTIVIRAL EFFECT WITH ITS PH VALUE | MERTOGLU HACI MURAT (TR) | 2022-06-02 | — | — | WO | claimed |
| EP-3886812-A1 | A NASAL SOLUTION WITH CLOSED BASIN NATURAL SPRING WATER CHARACTERISTIC AND METHOD FOR OBTAINING SAID NASAL SOLUTION | Yildiz Teknik Universitesi (TR) | 2021-10-06 | — | — | EP | claimed |
| WO-2020147020-A1 | RESIN-BASED COMPOSITE MATERIAL OF THREE-LAYER STRUCTURE AND USE THEREOF | 苏州大学 | 2020-07-23 | — | — | WO | claimed |
| WO-2020112063-A1 | A NASAL SOLUTION WITH CLOSED BASIN NATURAL SPRING WATER CHARACTERISTIC AND METHOD FOR OBTAINING SAID NASAL SOLUTION | YILDIZ TEKNIK UNIVERSITESI (TR) | 2020-06-04 | — | — | WO | claimed |
| US-20110006257-A1 | STABILIZED POWDERED FORMALDEHYDE | BIESECKER JAMES L | 2011-01-13 | — | — | US | claimed |
| WO-2025121354-A1 | NUCLEIC ACID BINDING PARTICLE AND METHOD FOR PRODUCING NUCLEIC ACID BINDING PARTICLE | 株式会社ニコン | 2025-06-12 | — | — | WO | disclosed |
| WO-2024092946-A1 | UNIVERSAL KIT AND METHOD FOR EXTRACTING MICROORGANISM DNA AND USE | 中山康源基因技术科技有限公司 | 2024-05-10 | — | — | WO | disclosed |
| CN-115028688-B | PCV3 Cap protein antigen peptide, antibody and PCV3 detection immunohistochemical kit | 山东信得科技股份有限公司 | 2024-04-16 | — | — | CN | disclosed |
| CN-116113826-A | Concentrating device, concentrating method for body fluid to be tested, testing method for body fluid to be tested, and testing kit | 富士胶片株式会社 | 2023-05-12 | — | — | CN | disclosed |
| WO-2022115069-A2 | NASAL SOLUTION WITH ANTIVIRAL EFFECT WITH ITS PH VALUE | MERTOGLU HACI MURAT (TR) | 2022-06-02 | — | — | WO | disclosed |
| US-20220000909-A1 | A NASAL SOLUTION WITH CLOSED BASIN NATURAL SPRING WATER CHARACTERISTIC AND METHOD FOR OBTAINING SAID NASAL SOLUTION | YILDIZ TEKNIK UNIVERSITESI (TR) | 2022-01-06 | — | — | US | disclosed |
| EP-3886812-A1 | A NASAL SOLUTION WITH CLOSED BASIN NATURAL SPRING WATER CHARACTERISTIC AND METHOD FOR OBTAINING SAID NASAL SOLUTION | Yildiz Teknik Universitesi (TR) | 2021-10-06 | — | — | EP | disclosed |
| US-4367221-A | INJECTIONS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1983-01-04 | — | — | US | disclosed |
| US-4367222-A | ANTIGENS,INJECTIONS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1983-01-04 | — | — | US | disclosed |
| US-4367223-A | IMMUNIZATION | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1983-01-04 | — | — | US | disclosed |
| US-4356263-A | AGAINST GROUP B STREPTOCOCCI, CULTURES, GLUCOSE, ANTIGENS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1982-10-26 | — | — | US | disclosed |
| US-4324887-A | ANTIGEN CONTAINING N-ACETYLGLOCOSAMINE, GALACTOSE, GLYCOSE, AND SIALIC ACID | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1982-04-13 | — | — | US | disclosed |
| EP-0041897-A2 | Polysaccharide antigen from streptococcus and vaccines | THE PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1981-12-16 | — | — | EP | disclosed |
| US-4207414-A | STREPTOCOCCUS CULTURES IN GLUCOSE | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1980-06-10 | — | — | US | disclosed |
| EP-0008969-A2 | Vaccine and method of making | THE PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1980-03-19 | — | — | EP | disclosed |